Ładuje się......
Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
Introduction Concurrent chemoradiation is the standard of care in inoperable locally advanced squamous cell head and neck cancers. The most widely accepted schedule of concomitant cisplatin is 100mg/m(2) given on a 3 weekly basis but the optimal regime is unknown. Objective The objective of this stu...
Zapisane w:
| Wydane w: | Int Arch Otorhinolaryngol |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Thieme-Revinter Publicações Ltda
2016
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5375948/ https://ncbi.nlm.nih.gov/pubmed/28382126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0036-1594020 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|